Eli Lilly seeking fast-track FDA approval for obesity drug tirzepatide

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

#elililly #fda #news

"CBS Evening News with Norah O'Donnell" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the "CBS Evening News" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app.

Subscribe to the "CBS Evening News" YouTube channel: https://bit.ly/1S7Dhik
Watch full episodes of "CBS Evening News": https://cbsn.ws/23XekKA
Follow "CBS Evening News" on Instagram: https://bit.ly/1T8icTO
Like "CBS Evening News" on Facebook: https://on.fb.me/1KxYobb
Follow "CBS Evening News" on Twitter: https://bit.ly/1O3dTTe
Download the CBS News app: https://cbsn.ws/1Xb1WC8
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: [email protected]